| Dr Benjamin David Ferguson, MD, PHD | |
|
1500 E Medical Center Dr, Ann Arbor, MI 48109-5000 | |
| (734) 936-4000 | |
| Not Available |
| Full Name | Dr Benjamin David Ferguson |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 11 Years |
| Location | 1500 E Medical Center Dr, Ann Arbor, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942648837 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Michigan Health System | Ann arbor, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Regents Of The University Of Michigan | 3779496856 | 2953 |
News Archive
More than 100 million Americans are expected to make a New Year's resolution this year. Losing weight and developing healthy habits, like eating healthy and exercising, are among the top three most common goals.
Perrigo today announced that its licensor and supplier Synthon has received final approval from the U.S. Food and Drug Administration (FDA) for Levocetirizine tablets, a generic version of Xyzal® tablets from UCB/Sepracor, which is marketed in the U.S. by Sanofi-Aventis. Perrigo has the exclusive rights from Synthon to sell and distribute the product in the U.S.
A recent study published in the February 2015 issue of the Journal of the American Academy of Child and Adolescent Psychiatry demonstrates that children who were abandoned to institutional care have an increased risk for behaviors similar to those seen in children with autism, including impaired social communication.
Researchers at the University of Pennsylvania School of Medicine report a novel strategy for stimulating the production of utrophin – an important muscle protein in young mice – for muscular dystrophy therapy.
› Verified 8 days ago
| Entity Name | Regents Of The University Of Michigan |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205868353 PECOS PAC ID: 3779496856 Enrollment ID: O20031106000325 |
News Archive
More than 100 million Americans are expected to make a New Year's resolution this year. Losing weight and developing healthy habits, like eating healthy and exercising, are among the top three most common goals.
Perrigo today announced that its licensor and supplier Synthon has received final approval from the U.S. Food and Drug Administration (FDA) for Levocetirizine tablets, a generic version of Xyzal® tablets from UCB/Sepracor, which is marketed in the U.S. by Sanofi-Aventis. Perrigo has the exclusive rights from Synthon to sell and distribute the product in the U.S.
A recent study published in the February 2015 issue of the Journal of the American Academy of Child and Adolescent Psychiatry demonstrates that children who were abandoned to institutional care have an increased risk for behaviors similar to those seen in children with autism, including impaired social communication.
Researchers at the University of Pennsylvania School of Medicine report a novel strategy for stimulating the production of utrophin – an important muscle protein in young mice – for muscular dystrophy therapy.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Benjamin David Ferguson, MD, PHD 3621 S State St, Ann Arbor, MI 48108-1633 Ph: (734) 647-5299 | Dr Benjamin David Ferguson, MD, PHD 1500 E Medical Center Dr, Ann Arbor, MI 48109-5000 Ph: (734) 936-4000 |
News Archive
More than 100 million Americans are expected to make a New Year's resolution this year. Losing weight and developing healthy habits, like eating healthy and exercising, are among the top three most common goals.
Perrigo today announced that its licensor and supplier Synthon has received final approval from the U.S. Food and Drug Administration (FDA) for Levocetirizine tablets, a generic version of Xyzal® tablets from UCB/Sepracor, which is marketed in the U.S. by Sanofi-Aventis. Perrigo has the exclusive rights from Synthon to sell and distribute the product in the U.S.
A recent study published in the February 2015 issue of the Journal of the American Academy of Child and Adolescent Psychiatry demonstrates that children who were abandoned to institutional care have an increased risk for behaviors similar to those seen in children with autism, including impaired social communication.
Researchers at the University of Pennsylvania School of Medicine report a novel strategy for stimulating the production of utrophin – an important muscle protein in young mice – for muscular dystrophy therapy.
› Verified 8 days ago
John C Magee, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Steven W Bruch, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1500 East Medical Center Dr., 4th Floor, C.s. Mott Children's Hospital, Ann Arbor, MI 48109 Phone: 734-764-4151 | |
Theodore Hobart Welling, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1500 East Medical Center Dr, 2nd Floor Taubman Ctr Recp F, Ann Arbor, MI 48109 Phone: 734-936-5738 | |
Eiichi A Miyasaka, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Department Of Surgery, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Nathan Louras, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Robert J Beaulieu, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Meredith Barrett, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 |